Poplar Forest Capital’s Elevance Health ELV Stock Holding History

Poplar Forest Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,050	Closed	-$943K	–	55
2023 Q1	$943K	Buy	+2,050	New	+$976K	0.11%	42
2022 Q4	–	Sell	-645	Closed	-$293K	–	63
2022 Q3	$293K	Sell	645 -215	-25%	-$103K	0.04%	45
2022 Q2	$415K	Sell	860 -13	-1%	-$6.43K	0.05%	47
2022 Q1	$429K	Sell	873 -5	-0.6%	-$2.29K	0.04%	48
2021 Q4	$407K	Sell	878 -31	-3%	-$13K	0.04%	47
2021 Q3	$339K	Sell	909 -839	-48%	-$319K	0.03%	64
2021 Q2	$667K	Buy	1,748 +26	+2%	+$9.94K	0.07%	43
2021 Q1	$618K	Buy	1,722 +1,001	+139%	+$322K	0.06%	43
2020 Q4	$232K	Sell	721 -2,293	-76%	-$704K	0.03%	77
2020 Q3	$810K	Buy	3,014 +2	+0.1%	+$538	0.1%	43
2020 Q2	$792K	Sell	3,012 -6	-0.2%	-$1.6K	0.09%	43
2020 Q1	$685K	Buy	+3,018	New	+$822K	0.1%	49

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Poplar Forest Capital's ELV Position: Q2 2023 in Review

Poplar Forest Capital sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 2,050 shares — an estimated $943K sold.

Poplar Forest Capital first reported a position in ELV in Q1 2020 and held it in 12 quarters. The position peaked at $943K in Q1 2023. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

Poplar Forest Capital reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
Poplar Forest Capital sold 2,050 Elevance Health shares in Q2 2023, an estimated $943K.
Poplar Forest Capital first reported a position in Elevance Health in Q1 2020 and held it in 12 quarters.
Poplar Forest Capital's Elevance Health position peaked at $943K in Q1 2023.
1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Poplar Forest Capital's 13F filing for Q2 2023, filed 2 Aug 2023.